BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9667660)

  • 1. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
    Kaklamanis L; Savage A; Whitehouse R; Doussis-Anagnostopoulou I; Biddolph S; Tsiotos P; Mortensen N; Gatter KC; Harris AL
    Br J Cancer; 1998 Jun; 77(11):1864-9. PubMed ID: 9667660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
    Tollenaar RA; van Krieken JH; van Slooten HJ; Bruinvels DJ; Nelemans KM; van den Broek LJ; Hermans J; van Dierendonck JH
    Br J Cancer; 1998 Jun; 77(11):1842-7. PubMed ID: 9667656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.
    Zhao DP; Ding XW; Peng JP; Zheng YX; Zhang SZ
    J Zhejiang Univ Sci B; 2005 Dec; 6(12):1163-9. PubMed ID: 16358373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
    Ilyas M; Hao XP; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Bodmer WF; Talbot IC
    Gut; 1998 Sep; 43(3):383-7. PubMed ID: 9863484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
    Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
    World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
    Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
    Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
    Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
    Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong
    Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
    Fante R; Di Gregorio C; Losi L; Roncucci L; Ponz de Leon M
    Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
    Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
    J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 protein expression is associated with better prognosis in colorectal cancer.
    Leahy DT; Mulcahy HE; O'Donoghue DP; Parfrey NA
    Histopathology; 1999 Oct; 35(4):360-7. PubMed ID: 10564391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
    Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
    Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation-related markers in colorectal liver metastases: correlation with patient prognosis.
    Costa A; Doci R; Mochen C; Bignami P; Faranda A; Gennari L; Silvestrini R
    J Clin Oncol; 1997 May; 15(5):2008-14. PubMed ID: 9164212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.
    Ofner D; Riehemann K; Maier H; Riedmann B; Nehoda H; Tötsch M; Böcker W; Jasani B; Schmid KW
    Br J Cancer; 1995 Oct; 72(4):981-5. PubMed ID: 7547253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.